NCT05927519 Comparison of Airtraq in Class 2-3 Obese and Nonobese Men During Intubation: a Prospective Randomized Clinical Study
| NCT ID | NCT05927519 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kocaeli University |
| Condition | Obesity, Morbid |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-10-25 |
| Primary Completion | 2027-10-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-10-25 with a primary completion date of 2027-10-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Morbid obesity is a growing disease. Intubations of these patients mostly difficult. Video laryngoscopes have to be used during the intubation of these patients. The intubation of men is more complicated and difficult than obese women. There were no trials compared to the new video laryngoscopes in morbidly obese men. Patients will be divided into two groups; non-obese and klas 2-3 obese. Airtraq will be used for their intubation. The time for intubation will be the primary aim of this prospective randomized study. The insertion time, perioperative hemodynamic variables, and postoperative complications will also be recorded.
Eligibility Criteria
Inclusion Criteria:\> 18 age men gender elective operation requring intuabtion - Exclusion Criteria:\<18 age women emergency operation \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05927519 clinical trial?
This trial is open to male participants only, aged 18 Years or older, up to 80 Years, studying Obesity, Morbid. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05927519 currently recruiting?
Yes, NCT05927519 is actively recruiting participants. Contact the research team at zehraipek48@gmail.com for enrollment information.
Where is the NCT05927519 trial being conducted?
This trial is being conducted at Iamit, Turkey (Türkiye), Kocaeli, Turkey (Türkiye).
Who is sponsoring the NCT05927519 clinical trial?
NCT05927519 is sponsored by Kocaeli University. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.